Literature DB >> 17472297

Dupuytren's disease: anatomy, pathology, presentation, and treatment.

Ghazi M Rayan1.   

Abstract

The disorder called Dupuytren's disease has been recognized for approximately 400 years. Its presentation, although seemingly rather constant, is actually extremely variable, depending on which structures are involved. A thorough knowledge of palmar fascial anatomy is essential to the understanding of Dupuytren's disease.

Entities:  

Mesh：

Year:  2007        PMID： 17472297

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN： 0065-6895


  8 in total

1.  Calcium-dependent signaling in Dupuytren's disease.

Authors:  Josef G Hadeed; Jennifer E Bond; M Angelica Selim; Andrew Bergeron; L Scott Levin; Howard Levinson
Journal:  Hand (N Y)       Date:  2010-12-15

2.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

3.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423

4.  Dupuytren's Disease: Review of the Current Literature.

Authors:  Morsi Khashan; Peter J Smitham; Wasim S Khan; Nicholas J Goddard
Journal:  Open Orthop J       Date:  2011-07-28

5.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

6.  Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.

Authors:  Jagdeep Nanchahal; Catherine Ball; Dominique Davidson; Lynn Williams; William Sones; Fiona E McCann; Marisa Cabrita; Jennifer Swettenham; Neil J Cahoon; Bethan Copsey; E Anne Francis; Peter C Taylor; Joanna Black; Vicki S Barber; Susan Dutton; Marc Feldmann; Sarah E Lamb
Journal:  EBioMedicine       Date:  2018-07-06       Impact factor: 8.143

7.  Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.

Authors:  Jagdeep Nanchahal; Catherine Ball; Jennifer Swettenham; Susan Dutton; Vicki Barber; Joanna Black; Bethan Copsey; Melina Dritsaki; Peter Taylor; Alastair Gray; Marc Feldmann; Sarah Lamb
Journal:  Wellcome Open Res       Date:  2017-06-06

8.  Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren's contracture.

Authors:  Nathalia Shchudlo; Tatyana Varsegova; Tatyana Stupina; Tamara Dolganova; Michael Shchudlo; Nathalia Shihaleva; Vadim Kostin
Journal:  World J Orthop       Date:  2018-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.